Improving Cancer On-treatment Symptom Management

Study summary

Patient-reported outcome measures (PROMs) is an umbrella term that refers to any report on a health status measure that is reported directly by the patient, without the influence of clinicians or anyone else. PROMs have been shown to more closely reflect a patient's daily health status when compared to physician-reported measures. However, research is needed to evaluate if patient symptom reporting during definitive-intent radiotherapy allows earlier and improved detection of treatment toxicity. The IMPROVE pilot study will describe the proportion of patients with cancer with changes in physician-perception of treatment-related toxicity that result from routine physician review of PROMs reported during definitive radiotherapy.

Ask AI to explain this study

Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forCancer · Thoracic Neoplasms

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 25, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?4 U.S. locations

Locations may change over time.

Who runs it?Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Study sponsor

Study overview

What this study is about

Purpose: Not specified
Study type: Observational
Phase: Not applicable
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Interventions being studied: Not specified

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Radiation therapy→Supportive or behavioral care→

Study topics

Survivorship and quality of life→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Men and women over 18 years of age
Able to read and write in English or able to understand/answer questions with the aid of an interpreter
Histologically confirmed loco-regional to advanced primary cancer, including but not limited to lung cancer, esophageal, or gastro-intestinal cancers at risk of developing radiotherapy-related toxicity.
Receiving definitive conventionally-fractionated radiation treatment with or without chemotherapy

Reasons someone may not be able to joinExclusion criteria

Patients receiving radiation for palliative intent
Patients who do not provide informed consent
Patients who chose to withdraw from the study Radiation Oncologists Inclusion criteria:
Must be the physician overseeing the care of the patient who answers the PROMS

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Bayview Medical CenterBaltimore, Maryland
Khinh VoongBaltimore, Maryland
Johns Hopkins Sidney Kimmel Comprehensive Cancer CenterBaltimore, Maryland
Suburban HospitalBethesda, Maryland

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 25, 2025. Always confirm current availability with the study team.

View original record ↗